Diffusion-weighted Whole-body Imaging with Background Body Signal Suppression (DWIBS) as a Novel Imaging Modality for Disease Activity Assessment in Takayasu's Arteritis

A 26-year-old woman with Takayasu's arteritis (TAK) experienced back and neck pain during tocilizumab (TCZ) treatment. The levels of C-reactive protein were normal, and ultrasonography revealed no significant changes. Diffusion-weighted whole-body imaging with background body signal suppression...

Descripción completa

Detalles Bibliográficos
Autores principales: Oguro, Eri, Ohshima, Shiro, Kikuchi-Taura, Akie, Murata, Atsuko, Kuzuya, Kentaro, Okita, Yasutaka, Matsuoka, Hidetoshi, Teshigawara, Satoru, Yoshimura, Maiko, Yoshida, Yuji, Isoda, Kentaro, Kudo-Tanaka, Eriko, Harada, Yoshinori, Kaminou, Toshio, Saeki, Yukihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543213/
https://www.ncbi.nlm.nih.gov/pubmed/30626815
http://dx.doi.org/10.2169/internalmedicine.1792-18
_version_ 1783423062504374272
author Oguro, Eri
Ohshima, Shiro
Kikuchi-Taura, Akie
Murata, Atsuko
Kuzuya, Kentaro
Okita, Yasutaka
Matsuoka, Hidetoshi
Teshigawara, Satoru
Yoshimura, Maiko
Yoshida, Yuji
Isoda, Kentaro
Kudo-Tanaka, Eriko
Harada, Yoshinori
Kaminou, Toshio
Saeki, Yukihiko
author_facet Oguro, Eri
Ohshima, Shiro
Kikuchi-Taura, Akie
Murata, Atsuko
Kuzuya, Kentaro
Okita, Yasutaka
Matsuoka, Hidetoshi
Teshigawara, Satoru
Yoshimura, Maiko
Yoshida, Yuji
Isoda, Kentaro
Kudo-Tanaka, Eriko
Harada, Yoshinori
Kaminou, Toshio
Saeki, Yukihiko
author_sort Oguro, Eri
collection PubMed
description A 26-year-old woman with Takayasu's arteritis (TAK) experienced back and neck pain during tocilizumab (TCZ) treatment. The levels of C-reactive protein were normal, and ultrasonography revealed no significant changes. Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) showed signal enhancement in the walls of several arteries. Contrast computed tomography showed arterial inflammation in the same lesion. After increasing the dose of prednisolone and TCZ, all signal enhancements decreased and continued to decrease, as observed on days 76 and 132. Thus, DWIBS may be a novel imaging modality for assessing the disease activity of TAK, particularly during follow-up.
format Online
Article
Text
id pubmed-6543213
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher The Japanese Society of Internal Medicine
record_format MEDLINE/PubMed
spelling pubmed-65432132019-06-03 Diffusion-weighted Whole-body Imaging with Background Body Signal Suppression (DWIBS) as a Novel Imaging Modality for Disease Activity Assessment in Takayasu's Arteritis Oguro, Eri Ohshima, Shiro Kikuchi-Taura, Akie Murata, Atsuko Kuzuya, Kentaro Okita, Yasutaka Matsuoka, Hidetoshi Teshigawara, Satoru Yoshimura, Maiko Yoshida, Yuji Isoda, Kentaro Kudo-Tanaka, Eriko Harada, Yoshinori Kaminou, Toshio Saeki, Yukihiko Intern Med Case Report A 26-year-old woman with Takayasu's arteritis (TAK) experienced back and neck pain during tocilizumab (TCZ) treatment. The levels of C-reactive protein were normal, and ultrasonography revealed no significant changes. Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) showed signal enhancement in the walls of several arteries. Contrast computed tomography showed arterial inflammation in the same lesion. After increasing the dose of prednisolone and TCZ, all signal enhancements decreased and continued to decrease, as observed on days 76 and 132. Thus, DWIBS may be a novel imaging modality for assessing the disease activity of TAK, particularly during follow-up. The Japanese Society of Internal Medicine 2019-01-10 2019-05-01 /pmc/articles/PMC6543213/ /pubmed/30626815 http://dx.doi.org/10.2169/internalmedicine.1792-18 Text en Copyright © 2019 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/ The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Oguro, Eri
Ohshima, Shiro
Kikuchi-Taura, Akie
Murata, Atsuko
Kuzuya, Kentaro
Okita, Yasutaka
Matsuoka, Hidetoshi
Teshigawara, Satoru
Yoshimura, Maiko
Yoshida, Yuji
Isoda, Kentaro
Kudo-Tanaka, Eriko
Harada, Yoshinori
Kaminou, Toshio
Saeki, Yukihiko
Diffusion-weighted Whole-body Imaging with Background Body Signal Suppression (DWIBS) as a Novel Imaging Modality for Disease Activity Assessment in Takayasu's Arteritis
title Diffusion-weighted Whole-body Imaging with Background Body Signal Suppression (DWIBS) as a Novel Imaging Modality for Disease Activity Assessment in Takayasu's Arteritis
title_full Diffusion-weighted Whole-body Imaging with Background Body Signal Suppression (DWIBS) as a Novel Imaging Modality for Disease Activity Assessment in Takayasu's Arteritis
title_fullStr Diffusion-weighted Whole-body Imaging with Background Body Signal Suppression (DWIBS) as a Novel Imaging Modality for Disease Activity Assessment in Takayasu's Arteritis
title_full_unstemmed Diffusion-weighted Whole-body Imaging with Background Body Signal Suppression (DWIBS) as a Novel Imaging Modality for Disease Activity Assessment in Takayasu's Arteritis
title_short Diffusion-weighted Whole-body Imaging with Background Body Signal Suppression (DWIBS) as a Novel Imaging Modality for Disease Activity Assessment in Takayasu's Arteritis
title_sort diffusion-weighted whole-body imaging with background body signal suppression (dwibs) as a novel imaging modality for disease activity assessment in takayasu's arteritis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543213/
https://www.ncbi.nlm.nih.gov/pubmed/30626815
http://dx.doi.org/10.2169/internalmedicine.1792-18
work_keys_str_mv AT oguroeri diffusionweightedwholebodyimagingwithbackgroundbodysignalsuppressiondwibsasanovelimagingmodalityfordiseaseactivityassessmentintakayasusarteritis
AT ohshimashiro diffusionweightedwholebodyimagingwithbackgroundbodysignalsuppressiondwibsasanovelimagingmodalityfordiseaseactivityassessmentintakayasusarteritis
AT kikuchitauraakie diffusionweightedwholebodyimagingwithbackgroundbodysignalsuppressiondwibsasanovelimagingmodalityfordiseaseactivityassessmentintakayasusarteritis
AT murataatsuko diffusionweightedwholebodyimagingwithbackgroundbodysignalsuppressiondwibsasanovelimagingmodalityfordiseaseactivityassessmentintakayasusarteritis
AT kuzuyakentaro diffusionweightedwholebodyimagingwithbackgroundbodysignalsuppressiondwibsasanovelimagingmodalityfordiseaseactivityassessmentintakayasusarteritis
AT okitayasutaka diffusionweightedwholebodyimagingwithbackgroundbodysignalsuppressiondwibsasanovelimagingmodalityfordiseaseactivityassessmentintakayasusarteritis
AT matsuokahidetoshi diffusionweightedwholebodyimagingwithbackgroundbodysignalsuppressiondwibsasanovelimagingmodalityfordiseaseactivityassessmentintakayasusarteritis
AT teshigawarasatoru diffusionweightedwholebodyimagingwithbackgroundbodysignalsuppressiondwibsasanovelimagingmodalityfordiseaseactivityassessmentintakayasusarteritis
AT yoshimuramaiko diffusionweightedwholebodyimagingwithbackgroundbodysignalsuppressiondwibsasanovelimagingmodalityfordiseaseactivityassessmentintakayasusarteritis
AT yoshidayuji diffusionweightedwholebodyimagingwithbackgroundbodysignalsuppressiondwibsasanovelimagingmodalityfordiseaseactivityassessmentintakayasusarteritis
AT isodakentaro diffusionweightedwholebodyimagingwithbackgroundbodysignalsuppressiondwibsasanovelimagingmodalityfordiseaseactivityassessmentintakayasusarteritis
AT kudotanakaeriko diffusionweightedwholebodyimagingwithbackgroundbodysignalsuppressiondwibsasanovelimagingmodalityfordiseaseactivityassessmentintakayasusarteritis
AT haradayoshinori diffusionweightedwholebodyimagingwithbackgroundbodysignalsuppressiondwibsasanovelimagingmodalityfordiseaseactivityassessmentintakayasusarteritis
AT kaminoutoshio diffusionweightedwholebodyimagingwithbackgroundbodysignalsuppressiondwibsasanovelimagingmodalityfordiseaseactivityassessmentintakayasusarteritis
AT saekiyukihiko diffusionweightedwholebodyimagingwithbackgroundbodysignalsuppressiondwibsasanovelimagingmodalityfordiseaseactivityassessmentintakayasusarteritis

Ejemplares similares